BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 35725739)

  • 1. Multimodal deep learning for Alzheimer's disease dementia assessment.
    Qiu S; Miller MI; Joshi PS; Lee JC; Xue C; Ni Y; Wang Y; De Anda-Duran I; Hwang PH; Cramer JA; Dwyer BC; Hao H; Kaku MC; Kedar S; Lee PH; Mian AZ; Murman DL; O'Shea S; Paul AB; Saint-Hilaire MH; Alton Sartor E; Saxena AR; Shih LC; Small JE; Smith MJ; Swaminathan A; Takahashi CE; Taraschenko O; You H; Yuan J; Zhou Y; Zhu S; Alosco ML; Mez J; Stein TD; Poston KL; Au R; Kolachalama VB
    Nat Commun; 2022 Jun; 13(1):3404. PubMed ID: 35725739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A parameter-efficient deep learning approach to predict conversion from mild cognitive impairment to Alzheimer's disease.
    Spasov S; Passamonti L; Duggento A; Liò P; Toschi N;
    Neuroimage; 2019 Apr; 189():276-287. PubMed ID: 30654174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment.
    Lombardi G; Crescioli G; Cavedo E; Lucenteforte E; Casazza G; Bellatorre AG; Lista C; Costantino G; Frisoni G; Virgili G; Filippini G
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009628. PubMed ID: 32119112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disease-driven domain generalization for neuroimaging-based assessment of Alzheimer's disease.
    Lteif D; Sreerama S; Bargal SA; Plummer BA; Au R; Kolachalama VB
    Hum Brain Mapp; 2024 Jun; 45(8):e26707. PubMed ID: 38798082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The new 2011 recommendations of the National Institute on Aging and the Alzheimer's Association on diagnostic guidelines for Alzheimer's disease: Preclinal stages, mild cognitive impairment, and dementia].
    Croisile B; Auriacombe S; Etcharry-Bouyx F; Vercelletto M; ;
    Rev Neurol (Paris); 2012 Jun; 168(6-7):471-82. PubMed ID: 22579080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Automated MRI-Based Deep Learning Model for Detection of Alzheimer's Disease Process.
    Feng W; Halm-Lutterodt NV; Tang H; Mecum A; Mesregah MK; Ma Y; Li H; Zhang F; Wu Z; Yao E; Guo X
    Int J Neural Syst; 2020 Jun; 30(6):2050032. PubMed ID: 32498641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating Alzheimer's Disease Progression Rates from Normal Cognition Through Mild Cognitive Impairment and Stages of Dementia.
    Davis M; O Connell T; Johnson S; Cline S; Merikle E; Martenyi F; Simpson K
    Curr Alzheimer Res; 2018; 15(8):777-788. PubMed ID: 29357799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential neuroimaging biomarkers of pathologic brain changes in Mild Cognitive Impairment and Alzheimer's disease: a systematic review.
    Ruan Q; D'Onofrio G; Sancarlo D; Bao Z; Greco A; Yu Z
    BMC Geriatr; 2016 May; 16():104. PubMed ID: 27184250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Revised criteria for mild cognitive impairment may compromise the diagnosis of Alzheimer disease dementia.
    Morris JC
    Arch Neurol; 2012 Jun; 69(6):700-8. PubMed ID: 22312163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroimaging markers for the prediction and early diagnosis of Alzheimer's disease dementia.
    Ewers M; Sperling RA; Klunk WE; Weiner MW; Hampel H
    Trends Neurosci; 2011 Aug; 34(8):430-42. PubMed ID: 21696834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zoom-In Neural Network Deep-Learning Model for Alzheimer's Disease Assessments.
    Wang B; Lim JS
    Sensors (Basel); 2022 Nov; 22(22):. PubMed ID: 36433486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A deep learning model for early prediction of Alzheimer's disease dementia based on hippocampal magnetic resonance imaging data.
    Li H; Habes M; Wolk DA; Fan Y;
    Alzheimers Dement; 2019 Aug; 15(8):1059-1070. PubMed ID: 31201098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarker-Based Prediction of Progression to Dementia: F-18 FDG-PET in Amnestic MCI.
    Tripathi M; Tripathi M; Parida GK; Kumar R; Dwivedi S; Nehra A; Bal C
    Neurol India; 2019; 67(5):1310-1317. PubMed ID: 31744965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deep Learning for Alzheimer's Disease Classification using Texture Features.
    So JH; Madusanka N; Choi HK; Choi BK; Park HG
    Curr Med Imaging Rev; 2019; 15(7):689-698. PubMed ID: 32008517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Data-Limited Deep Learning Methods for Mild Cognitive Impairment Classification in Alzheimer's Disease Patients.
    De Luna A; Marcia RF
    Annu Int Conf IEEE Eng Med Biol Soc; 2021 Nov; 2021():2641-2646. PubMed ID: 34891795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease.
    Apostolova LG; Hwang KS; Kohannim O; Avila D; Elashoff D; Jack CR; Shaw L; Trojanowski JQ; Weiner MW; Thompson PM;
    Neuroimage Clin; 2014; 4():461-72. PubMed ID: 24634832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multi-model deep convolutional neural network for automatic hippocampus segmentation and classification in Alzheimer's disease.
    Liu M; Li F; Yan H; Wang K; Ma Y; ; Shen L; Xu M
    Neuroimage; 2020 Mar; 208():116459. PubMed ID: 31837471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 3D deep learning model to predict the diagnosis of dementia with Lewy bodies, Alzheimer's disease, and mild cognitive impairment using brain 18F-FDG PET.
    Etminani K; Soliman A; Davidsson A; Chang JR; Martínez-Sanchis B; Byttner S; Camacho V; Bauckneht M; Stegeran R; Ressner M; Agudelo-Cifuentes M; Chincarini A; Brendel M; Rominger A; Bruffaerts R; Vandenberghe R; Kramberger MG; Trost M; Nicastro N; Frisoni GB; Lemstra AW; van Berckel BNM; Pilotto A; Padovani A; Morbelli S; Aarsland D; Nobili F; Garibotto V; Ochoa-Figueroa M
    Eur J Nucl Med Mol Imaging; 2022 Jan; 49(2):563-584. PubMed ID: 34328531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting progression from mild cognitive impairment to Alzheimer's disease on an individual subject basis by applying the CARE index across different independent cohorts.
    Chen J; Chen G; Shu H; Chen G; Ward BD; Wang Z; Liu D; Antuono PG; Li SJ; Zhang Z;
    Aging (Albany NY); 2019 Apr; 11(8):2185-2201. PubMed ID: 31078129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive signature of brain FDG PET based on deep learning: domain transfer from Alzheimer's disease to Parkinson's disease.
    Choi H; Kim YK; Yoon EJ; Lee JY; Lee DS;
    Eur J Nucl Med Mol Imaging; 2020 Feb; 47(2):403-412. PubMed ID: 31768599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.